11 results on '"Bellmann-Weiler, Rosa"'
Search Results
2. Alterations of blood monocyte subset distribution and surface phenotype are linked to infection severity in COVID‐19 inpatients.
- Author
-
Haschka, David, Petzer, Verena, Burkert, Francesco Robert, Fritsche, Gernot, Wildner, Sophie, Bellmann‐Weiler, Rosa, Tymoszuk, Piotr, and Weiss, Guenter
- Subjects
COVID-19 ,SELF-organizing maps ,PHENOTYPES ,FLOW cytometry ,LEUCOCYTES - Abstract
Severe coronavirus disease 19 (COVID‐19) manifests with systemic immediate proinflammatory innate immune activation and altered iron turnover. Iron homeostasis, differentiation, and function of myeloid leukocytes are interconnected. Therefore, we characterized the cellularity, surface marker expression, and iron transporter phenotype of neutrophils and monocyte subsets in COVID‐19 patients within 72 h from hospital admission, and analyzed how these parameters relate to infection severity. Between March and November 2020, blood leukocyte samples from hospitalized COVID‐19 patients (n = 48) and healthy individuals (n = 7) were analyzed by flow cytometry enabling comparative analysis of 40 features. Inflammation‐driven neutrophil expansion, depletion of CD16+ nonclassical monocytes, and changes in surface expression of neutrophil and monocyte CD64 and CD86 were associated with COVID‐19 severity. By unsupervised self‐organizing map clustering, four patterns of innate myeloid response were identified and linked to varying levels of systemic inflammation, altered cellular iron trafficking and the severity of disease. These alterations of the myeloid leukocyte compartment during acute COVID‐19 may be hallmarks of inefficient viral control and immune hyperactivation and may help at risk prediction and treatment optimization. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study.
- Author
-
Rass, Verena, Beer, Ronny, Schiefecker, Alois Josef, Kofler, Mario, Lindner, Anna, Mahlknecht, Philipp, Heim, Beatrice, Limmert, Victoria, Sahanic, Sabina, Pizzini, Alex, Sonnweber, Thomas, Tancevski, Ivan, Scherfler, Christoph, Zamarian, Laura, Bellmann‐Weiler, Rosa, Weiss, Günter, Djamshidian, Atbin, Kiechl, Stefan, Seppi, Klaus, and Loeffler‐Ragg, Judith
- Subjects
MENTAL illness ,COVID-19 ,MELAS syndrome ,QUALITY of life ,NEUROLOGICAL disorders ,NEUROLOGIC manifestations of general diseases ,PSYCHOLOGICAL manifestations of general diseases - Abstract
Background and purpose: To assess neurological manifestations and health‐related quality of life (QoL) 3 months after COVID‐19. Methods: In this prospective, multicenter, observational cohort study we systematically evaluated neurological signs and diseases by detailed neurological examination and a predefined test battery assessing smelling disorders (16‐item Sniffin Sticks test), cognitive deficits (Montreal Cognitive Assessment), QoL (36‐item Short Form), and mental health (Hospital Anxiety and Depression Scale, Posttraumatic Stress Disorder Checklist–5) 3 months after disease onset. Results: Of 135 consecutive COVID‐19 patients, 31 (23%) required intensive care unit (ICU) care (severe), 72 (53%) were admitted to the regular ward (moderate), and 32 (24%) underwent outpatient care (mild) during acute disease. At the 3‐month follow‐up, 20 patients (15%) presented with one or more neurological syndromes that were not evident before COVID‐19. These included polyneuro/myopathy (n = 17, 13%) with one patient presenting with Guillain‐Barré syndrome, mild encephalopathy (n = 2, 2%), parkinsonism (n = 1, 1%), orthostatic hypotension (n = 1, 1%), and ischemic stroke (n = 1, 1%). Objective testing revealed hyposmia/anosmia in 57/127 (45%) patients at the 3‐month follow‐up. Self‐reported hyposmia/anosmia was lower (17%) at 3 months, however, improved when compared to the acute disease phase (44%; p < 0.001). At follow‐up, cognitive deficits were apparent in 23%, and QoL was impaired in 31%. Assessment of mental health revealed symptoms of depression, anxiety, and posttraumatic stress disorders in 11%, 25%, and 11%, respectively. Conclusions: Despite recovery from the acute infection, neurological symptoms were prevalent at the 3‐month follow‐up. Above all, smelling disorders were persistent in a large proportion of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Muscle involvement in SARS‐CoV‐2 infection.
- Author
-
Pitscheider, Lea, Karolyi, Mario, Burkert, Francesco R., Helbok, Raimund, Wanschitz, Julia V., Horlings, Corinne, Pawelka, Erich, Omid, Sara, Traugott, Marianna, Seitz, Tamara, Zoufaly, Alexander, Lindeck‐Pozza, Elisabeth, Wöll, Ewald, Beer, Ronny, Seiwald, Stefanie, Bellmann‐Weiler, Rosa, Hegen, Harald, and Löscher, Wolfgang N.
- Subjects
INFLUENZA ,SARS-CoV-2 ,COVID-19 ,CREATINE kinase - Abstract
Background and Purpose: Since the outbreak of the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) pandemic, several reports indicated neurological involvement in COVID‐19 disease. Muscle involvement has also been reported as evidenced by creatine kinase (CK) elevations and reports of myalgia. Methods: Creatine kinase, markers of inflammation, pre‐existing diseases and statin use were extracted from records of Austrian hospitalised COVID‐19 patients. Disease severity was classified as severe in case of intensive care unit (ICU) admission or mortality. COVID‐19 patients were additionally compared to an historical group of hospitalised influenza patients. Results: Three hundred fifty‐one patients with SARS‐CoV‐2 and 258 with influenza were included in the final analysis. CK was elevated in 27% of COVID‐19 and in 28% of influenza patients. CK was higher in severe COVID‐19 as were markers of inflammation. CK correlated significantly with inflammation markers, which had an independent impact on CK when adjusted for demographic variables and disease severity. Compared to influenza patients, COVID‐19 patients were older, more frequently male, had more comorbidities, and more frequently had a severe disease course. Nevertheless, influenza patients had higher baseline CK than COVID‐19, and 35.7% of intensive care unit (ICU)‐admitted patients had CK levels >1,000 U/L compared to only 4.7% of ICU‐admitted COVID‐19 patients. Conclusions: HyperCKemia occurs in a similar frequency in COVID‐19 and influenza infection. CK levels were lower in COVID‐19 than in influenza in mild and severe disease. CK levels strongly correlate with disease severity and markers of inflammation. To date, it remains unclear whether hyperCKemia is due to a virus‐triggered inflammatory response or direct muscle toxicity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Clonal hematopoiesis in patients with Covid‐19 is stable and not linked to an aggravated clinical course.
- Author
-
Petzer, Verena, Schwendinger, Simon, Haschka, David, Vogi, Verena, Tymoszuk, Piotr, Burkert, Francesco, Sahanic, Sabina, Sonnweber, Thomas, Bellmann‐Weiler, Rosa, Loeffler‐Ragg, Judith, Tancevski, Ivan, Zschocke, Johannes, Weiss, Guenter, Wolf, Dominik, and Jukic, Emina
- Published
- 2021
- Full Text
- View/download PDF
6. Assessment of neopterin and indoleamine 2,3‐dioxygenase activity in patients with seasonal influenza: A pilot study.
- Author
-
Pizzini, Alex, Kurz, Katharina, Santifaller, Janine, Tschurtschenthaler, Christoph, Theurl, Igor, Fuchs, Dietmar, Weiss, Günter, and Bellmann‐Weiler, Rosa
- Subjects
INDOLEAMINE 2,3-dioxygenase ,SEASONAL influenza ,PILOT projects ,NEOPTERIN ,TRYPTOPHAN - Abstract
Background: Seasonal influenza is an important cause of morbidity and mortality worldwide. Immune activation after stimulation with interferon‐gamma leads to increased production of neopterin but also results in increased tryptophan catabolism through indoleamine 2,3‐dioxygenase (IDO). Our pilot study determined neopterin serum levels and IDO activity in patients with influenza infection and investigated whether neopterin is linked to clinical outcome parameters (mortality ≤30 days, acute cardiac events (ACE) length of hospitalization, ICU admission). Methods: Neopterin concentrations were analyzed in serum samples of 40 patients with a confirmed diagnosis of influenza infection and in‐hospital treatment for >24 hours. Data were compared to values of 100 healthy blood donors and 48 age‐matched pneumonia patients. In a subgroup of 14 patients, tryptophan and kynurenine concentrations, as well as kynurenine‐to‐tryptophan ratio, were analyzed. Results: In all influenza patients, neopterin concentrations were increased and significantly higher compared to those determined in patients with pneumonia and healthy controls. Positive correlations between the duration of hospitalization and neopterin were found. Significantly higher levels of kynurenine, kynurenine‐to‐tryptophan ratio, and lower levels of tryptophan were seen in influenza patients compared to healthy controls. Conclusions: Neopterin seems to be related to the course of the disease and could be a valuable biomarker to identify patients at an elevated risk of a worsened outcome; however, further prospective validation studies are needed to support the here presented preliminary results. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
7. Janus‐faced course of COVID‐19 infection in patients with hematological malignancies.
- Author
-
Bellmann‐Weiler, Rosa, Burkert, Francesco, Schwaiger, Theresa, Schmidt, Stephan, Ludescher, Christof, Oexle, Horst, Wolf, Dominik, and Weiss, Günter
- Subjects
- *
HEMATOLOGIC malignancies , *COVID-19 , *ACUTE myeloid leukemia , *BETA lactam antibiotics , *INFECTION - Published
- 2020
- Full Text
- View/download PDF
8. Lipocalin-2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response.
- Author
-
Nairz, Manfred, Schroll, Andrea, Haschka, David, Dichtl, Stefanie, Sonnweber, Thomas, Theurl, Igor, Theurl, Milan, Lindner, Ewald, Demetz, Egon, Aßhoff, Malte, Bellmann‐Weiler, Rosa, Müller, Raphael, Gerner, Romana R., Moschen, Alexander R., Baumgartner, Nadja, Moser, Patrizia L., Talasz, Heribert, Tilg, Herbert, Fang, Ferric C., and Weiss, Günter
- Abstract
Lipocalin-2 (Lcn2) is an innate immune peptide with pleiotropic effects. Lcn2 binds iron-laden bacterial siderophores, chemo-attracts neutrophils and has immunomodulatory and apoptosis-regulating effects. In this study, we show that upon infection with Salmonella enterica serovar Typhimurium, Lcn2 promotes iron export from Salmonella-infected macrophages, which reduces cellular iron content and enhances the generation of pro-inflammatory cytokines. Lcn2 represses IL-10 production while augmenting Nos2, TNF-α, and IL-6 expression. Lcn2
−/− macrophages have elevated IL-10 levels as a consequence of increased iron content. The crucial role of Lcn-2/IL-10 interactions was further demonstrated by the greater ability of Lcn2−/− IL-10−/− macrophages and mice to control intracellular Salmonella proliferation in comparison to Lcn2−/− counterparts. Overexpression of the iron exporter ferroportin-1 in Lcn2−/− macrophages represses IL-10 and restores TNF-α and IL-6 production to the levels found in wild-type macrophages, so that killing and clearance of intracellular Salmonella is promoted. Our observations suggest that Lcn2 promotes host resistance to Salmonella Typhimurium infection by binding bacterial siderophores and suppressing IL-10 production, and that both functions are linked to its ability to shuttle iron from macrophages. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
9. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.
- Author
-
Theurl, Igor, Finkenstedt, Armin, Schroll, Andrea, Nairz, Manfred, Sonnweber, Thomas, Bellmann-Weiler, Rosa, Theurl, Milan, Seifert, Markus, Wroblewski, Victor J., Murphy, Anthony T., Witcher, Derrick, Zoller, Heinz, and Weiss, Günter
- Subjects
IRON deficiency anemia ,CHRONIC diseases ,ERYTHROPOIESIS ,THALASSEMIA ,SERUM ,PATIENTS - Abstract
Recently, the iron and erythropoiesis-controlled growth differentiation factor 15 (GDF15) has been shown to inhibit the expression of hepcidin in β-thalassaemia patients, thereby increasing iron absorption despite iron overload. To access the diagnostic and pathogenic impact of GDF15 in inflammatory anaemia the association of GDF15 expression with serum iron parameters and hepcidin was studied in patients suffering from iron deficiency anaemia (IDA), anaemia of chronic disease (ACD) and ACD subjects with true iron deficiency (ACD/IDA). GDF15 was significantly increased in both ACD and ACD/IDA, but not in IDA subjects as compared to controls. In contrast, hepcidin levels were significantly lower in IDA and ACD/IDA subjects than in ACD patients . IDA and ACD/IDA, but not ACD, showed an association between GDF15 and soluble transferrin receptor, an indicator of iron requirement for erythropoiesis. However, GDF15 did not correlate to hepcidin in either patient group. While GDF15 levels were linked to the needs for erythropoiesis and iron homeostasis in IDA, the immunity-driven increase of GDF15 may not primarily affect iron homeostasis and hepcidin expression. This indicates that other ACD-related factors may overcome the regulatory effects of GDF15 on hepcidin expression during inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
10. Feasibility of Second-Generation Ultrasound Contrast Media in the. Detection of Active Sacroiliitis.
- Author
-
Klauser, Andrea S., de Zordo, Tobias, Bellmann-Weiler, Rosa, Feuchtner, Gudrun M., Sailer-Höck, Michaela, Sögner, Peter, and Gruber, Johann
- Subjects
CONTRAST media ,ULTRASOUND contrast media ,SACROILIAC joint ,JOINT disease diagnosis ,INFLAMMATION ,DIAGNOSTIC imaging equipment - Abstract
The article presents a study which evaluates the potential of a second-generation contrast agent for the detection of vascularity at the dorsocaudal part of the sacroiliac joints in patients with sacroiliitis. The subjects of the study were investigated by contrast-enhanced ultrasound (CEUS). It was found in the study that CEUS allowed the differentiation of acute sacroiliitis from inactive SI joint, and is a feasible method for the detection of vascularity in clinically active sacroiliitis.
- Published
- 2009
- Full Text
- View/download PDF
11. Pharmacokinetics of Liposomal Amphotericin B During Extracorporeal Albumin Dialysis.
- Author
-
Vogelsinger, Helene, Joannidis, Michael, Kountchev, Jordan, Bellmann-Weiler, Rosa, Wiedermann, Christian J., and Bellmann, Romuald
- Subjects
PHARMACOKINETICS ,PHARMACOLOGY ,AMPHOTERICIN B ,POLYENE antibiotics ,BLOOD plasma ,MYCOSES - Abstract
Extracorporeal blood purification techniques such as hemofiltration or albumin dialysis can exert a significant, but not easily predictable influence on plasma pharmacokinetics of antimicrobial agents. The effect of albumin dialysis on the pharmacokinetics of liposomal amphotericin B (AMB) and other lipid-formulated drugs has not been investigated so far. Therefore, plasma concentrations of liberated and liposomal AMB were measured in a patient, who obtained liposomal AMB for suspected invasive mycosis and required albumin dialysis because of cholestatic liver failure caused by graft versus host disease after bone marrow transplantation. Liberated and liposomal AMB were separated by solid phase extraction and measured by high performance liquid chromatography. No excessive AMB elimination took place during albumin dialysis. Plasma levels of liposomal AMB exceeded those of liberated AMB. Pharmacokinetic data were comparable to those obtained previously in patients on hemofiltration and in critically ill patients without extracorporeal blood purification. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.